Home LiteratureArticle Details
PMID: 308451 Published · ppublish English Journal Article

Grafting of triggering sites onto lymphocytes: requirement of multivalency in the stimulation of dinitrophenyl-modified thymocytes by anti-dinitrophenyl antibody.

European journal of immunology ·Vol. 8 ·No. 5 ·1978-05-00 ·Pages 289-94

Ravid A, Novogrodsky A, Wilchek M

Abstract

N4-Dinitrophenyl-L-2,4,-diaminobutyric acid hydrazide was coupled to aldehyde groups generated by periodate oxidation of sialyl residues on thymocytes. Anti-2,4-dinitrophenyl(Dnp)antibody was found to stimulate mature, hydrocortisone-resistant thymocytes, while it had no mitogenic effect on the immature thymocytes. In order to study the involvement of different regions of the antibody molecule in the triggering process of stimulation, the mitogenicity of various antibody fragments was also assessed. The divalent F(ab')2 was found to be a superior mitogen compared to the intact antibody when added to Dnp-conjugated thymocytes. The monovalent Fab' and Fab fragments have no mitogenic activity indicating that cross-linkage may be a prerequisite for stimulation.

MeSH Terms
Animals Antibodies Antigen-Antibody Reactions Antigens, Surface Dinitrobenzenes/immunology Immunoglobulin Fab Fragments Lymphocyte Activation Mice Mice, Inbred BALB C Mitogens T-Lymphocytes/immunology
Chemicals
Antibodies Antigens, Surface Dinitrobenzenes Immunoglobulin Fab Fragments Mitogens
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ravid A
Novogrodsky A
Wilchek M
Article Info
Journal
European journal of immunology
Abbr.
Eur J Immunol
ISSN
0014-2980
Published
1978-05-00
Pages
289-94
Language
English
Region
Germany
NLM ID
1273201
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]